MiR-186 inhibited the proliferation, migration, and invasion of glioma stem cells and promoted apoptosis via targeting XIAP and PAK7, thus regulating the expression levels of downstream target proteins such as caspase 3, BAD, cyclin D1, and MARK2 (42). The gene discussed is XIAP; the disease is central nervous system cancer.